Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?

被引:9
作者
Bergh, J [1 ]
机构
[1] Karolinska Hosp & Inst, Radiumhemmet, S-17176 Stockholm, Sweden
关键词
D O I
10.1016/S0140-6736(03)13951-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:183 / 184
页数:2
相关论文
共 13 条
[1]  
Abe O, 1998, LANCET, V352, P930
[2]  
Bergh J, 2001, J Natl Cancer Inst Monogr, P103
[3]   Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial [J].
Cauley, JA ;
Norton, L ;
Lippman, ME ;
Eckert, S ;
Krueger, KA ;
Purdie, DW ;
Farrerons, J ;
Karasik, A ;
Mellstrom, D ;
Ng, KW ;
Stepan, JJ ;
Powles, TJ ;
Morrow, M ;
Costa, A ;
Silfen, SL ;
Walls, EL ;
Schmitt, H ;
Muchmore, DB ;
Jordan, VC .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) :125-134
[4]  
Clarke M, 1998, LANCET, V351, P1451
[5]  
Cuzick J, 2002, LANCET, V360, P817
[6]   Overview of the main outcomes in breast-cancer prevention trials [J].
Cuzick, J ;
Powles, T ;
Veronesi, U ;
Forbes, J ;
Edwards, R ;
Ashley, S ;
Boyle, P .
LANCET, 2003, 361 (9354) :296-300
[7]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[8]   National surgical adjuvant breast and bowel project breast cancer prevention trial: A reflective commentary [J].
Fisher, B .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1632-1639
[9]   Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention [J].
Freedman, AN ;
Graubard, BI ;
Rao, SR ;
McCaskill-Stevens, W ;
Ballard-Barbash, R ;
Gail, MH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (07) :526-532
[10]  
Powles T, 1998, LANCET, V352, P98